Alnylam Pharmaceuticals, Inc. News - ALNY

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
SMALL CAP BASIC
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Alnylam Pharmaceuticals, Inc. ALNY NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  +1.84 +2.16% 87.21 87.325 83.5 84.9 85.37 14:25:09
more quote information »

Recent News

Date Time Source Heading
4/23/201916:00BWAlnylam to Webcast Conference Call Discussing First Quarter..
4/17/201916:07EDGARStatement of Changes in Beneficial Ownership (4)
4/15/201907:00BWAlnylam Initiates ILLUMINATE-B Phase 3 Pediatric Study of..
4/12/201918:01BWAlnylam Presents Positive Complete Results from ENVISION..
4/10/201909:20EDGARConfidential Treatment Order (ct Order)
4/10/201906:06EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/09/201916:44EDGARCurrent Report Filing (8-k)
4/08/201916:25EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/08/201907:00BWAlnylam & Regeneron Announce Broad Collaboration to..
4/08/201907:00PRNUSRegeneron and Alnylam Announce Broad Collaboration to..
4/08/201901:46DJNSanofi, Alnylam Complete Research Phase of Rare Disease..
4/08/201901:00BWAlnylam and Sanofi Conclude Research and Option Phase of..
3/27/201907:00BWAlnylam to Present Givosiran Phase 3 Data at the European..
3/21/201907:32EDGARProxy Statement (definitive) (def 14a)
3/18/201917:26EDGARProxy Soliciting Materials (revised) (prer14a)
3/11/201917:09EDGARProxy Statement - Notice of Shareholders Meeting..
3/11/201907:00BWAlnylam Submits CTA Application for ALN-AGT, an..
3/07/201916:00BWAlnylam to Webcast Presentation at Cowen & Company 39th..
3/06/201907:00BWAlnylam Reports Positive Topline Results from ENVISION Phase..
3/01/201918:51EDGARStatement of Changes in Beneficial Ownership (4)
3/01/201918:51EDGARStatement of Changes in Beneficial Ownership (4)
3/01/201918:39EDGARStatement of Changes in Beneficial Ownership (4)
3/01/201918:39EDGARStatement of Changes in Beneficial Ownership (4)
3/01/201918:35EDGARStatement of Changes in Beneficial Ownership (4)
3/01/201918:29EDGARStatement of Changes in Beneficial Ownership (4)
2/28/201915:41BWAlnylam annonce les bénéficiaires du premier programme..
2/28/201914:01BWAlnylam anuncia los destinatarios de subvenciones del primer..
2/28/201907:00BWAlnylam Announces Recipients of First Annual Advocacy for..
2/14/201918:29EDGARAnnual Report (10-k)
2/14/201914:01EDGARAmended Statement of Ownership (sc 13g/a)
2/14/201913:05EDGARAmended Statement of Ownership (sc 13g/a)
2/13/201911:46EDGARAmended Statement of Ownership (sc 13g/a)
2/12/201909:39EDGARSchedule 13g
2/11/201912:47EDGARAmended Statement of Ownership (sc 13g/a)
2/07/201916:17EDGARCurrent Report Filing (8-k)
2/07/201916:00BWAlnylam Pharmaceuticals Reports Fourth Quarter and Full Year..
2/06/201917:00BWAlnylam Announces Publication of Phase 1 Givosiran Data in..
2/04/201916:00BWAlnylam to Webcast Presentations at Upcoming February..
2/04/201910:17EDGARAmended Statement of Ownership (sc 13g/a)
1/31/201916:00BWAlnylam to Webcast Conference Call Discussing Fourth Quarter..
1/31/201915:11EDGARAmended Statement of Ownership (sc 13g/a)
1/22/201915:15EDGARStatement of Changes in Beneficial Ownership (4)
1/21/201916:58BWAlnylam Pharmaceuticals et Medison Pharma s'associent en vue..
1/21/201912:54BWAlnylam Pharmaceuticals und Medison Pharma kooperieren bei..
1/21/201903:00BWAlnylam Pharmaceuticals and Medison Pharma Partner to..
1/15/201917:21EDGARCurrent Report Filing (8-k)
1/15/201917:16EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
1/14/201921:13BWAlnylam Pharmaceuticals Prices Public Offering of Common..
1/14/201916:43EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
1/14/201916:04BWAlnylam Pharmaceuticals Announces Proposed Public Offering..
See more news about this stock »
Your Recent History
NASDAQ
ALNY
Alnylam Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190425 18:40:33